HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing multiple therapeutic platforms intended to enhance Treg ...

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on targeted cell therapies for autoimmune diseases, announced that updated clinical data on its investigational therapy, ...

Please provide your email address to receive an email when new articles are posted on . Attendees will get insights into evaluation and treatment of complications that arise from stem cell ...

We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Castle is ...

Preclinical in vitro studies demonstrated >80% reduction in protease activity, including complete inhibition of TACE and collagenase — key factors in non-healing chronic wounds revyve® data featured ...

FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc.

The 2023 Fall Clinical Dermatology conference featured research on treatments for alopecia areata, acne, psoriasis, atopic dermatitis, and vitiligo. The Fall Clinical Dermatology conference presented ...

Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma. Exploring the role of the combination of FDG-PET plus whole body MRI for staging ...

Staffordshire University is pleased to announce the 20th consecutive Conference on Clinical Biomechanics. As in the previous years, the conference provides a forum for information dissemination on ...

The MarketWatch News Department was not involved in the creation of this content. Dubai, United Arab Emirates--(Newsfile Corp. - October 31, 2025) - International Modern Hospital (IMH) successfully ...

The following content was published by The Lancet Group and presented at the most recent International Conference on AIDS and STIs in Africa.

The Global Clinical and Aesthetic Dermatology Conference (GCAD 2026) will take place October 26–28, 2026, in Boston, Massachusetts, United States and Online, bringing together an international ...